- Home
- MCHX vs PMVP Comparison
MCHX vs PMVP Comparison
Compare MCHX & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MCHX | PMVP |
|---|---|---|
| Founded | 2003 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.6M | 66.0M |
| IPO Year | 2004 | 2020 |
Fundamental Metrics
Financial Performance| Metric | MCHX | PMVP |
|---|---|---|
| Price | $1.68 | $1.22 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $5.00 |
| AVG Volume (30 Days) | 17.3K | ★ 269.9K |
| Earning Date | 11-13-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $46,494,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.70 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.26 | $0.81 |
| 52 Week High | $2.31 | $1.84 |
Technical Indicators
Market Signals| Indicator | MCHX | PMVP |
|---|---|---|
| Relative Strength Index (RSI) | 45.96 | 45.29 |
| Support Level | $1.60 | $1.20 |
| Resistance Level | $1.73 | $1.25 |
| Average True Range (ATR) | 0.07 | 0.06 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 20.01 | 59.46 |
Price Performance
Historical ComparisonAbout MCHX Marchex Inc. Class B
Marchex Inc harnesses the power of AI and conversational intelligence to provide actionable insights aligned with prescriptive vertical market data analytics, driving operational excellence and revenue acceleration. Marchex enables executive, sales, and marketing teams to optimize customer journey experiences across communications channels, enabling enterprise strategies, empowering businesses to increase revenue through informed decision-making and strategic execution.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.